Matthew J. Memoli

5.4k total citations · 1 hit paper
53 papers, 2.6k citations indexed

About

Matthew J. Memoli is a scholar working on Epidemiology, Infectious Diseases and Agronomy and Crop Science. According to data from OpenAlex, Matthew J. Memoli has authored 53 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 21 papers in Infectious Diseases and 7 papers in Agronomy and Crop Science. Recurrent topics in Matthew J. Memoli's work include Influenza Virus Research Studies (35 papers), Respiratory viral infections research (29 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Matthew J. Memoli is often cited by papers focused on Influenza Virus Research Studies (35 papers), Respiratory viral infections research (29 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). Matthew J. Memoli collaborates with scholars based in United States, United Kingdom and Netherlands. Matthew J. Memoli's co-authors include Jeffery K. Taubenberger, Daniel S. Chertow, David M. Morens, Tyler Bristol, Lindsay Czajkowski, Rani Athota, Alison Han, Susan Reed, Hillery A. Harvey and Maryna C. Eichelberger and has published in prestigious journals such as Science, The Lancet and JAMA.

In The Last Decade

Matthew J. Memoli

52 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity

2017 241 citations Taia T. Wang, Jaturong Sewatanon et al. Science profile →

Peers

Matthew J. Memoli

EPIDE

IMMUN

PHEOH

Sook‐San Wong United States

Natalie Pica United States

Karen Laurie Australia

Aneesh K. Mehta United States

Olav Hungnes Norway

Alison Bermingham United Kingdom

Leatrice Vogel United States

Nadine Rouphael United States

Fatima Amanat United States

Florence Morfin France

Sook‐San Wong United States

Matthew J. Memoli

1.3k ×0.8

EPIDE

781 ×0.8

404 ×0.7

IMMUN

359 ×0.8

178 ×0.6

PHEOH

Citations per year, relative to Matthew J. Memoli Matthew J. Memoli (= 1×) peers Sook‐San Wong

Countries citing papers authored by Matthew J. Memoli

Since Specialization

Citations

This map shows the geographic impact of Matthew J. Memoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Memoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Memoli more than expected).

Fields of papers citing papers by Matthew J. Memoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Memoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Memoli. The network helps show where Matthew J. Memoli may publish in the future.

Co-authorship network of co-authors of Matthew J. Memoli

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Memoli. A scholar is included among the top collaborators of Matthew J. Memoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Memoli. Matthew J. Memoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giurgea, Luca T., Alison Han, Lindsay Czajkowski, et al.. (2025). 593. Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations

Pérez‐Díez, Ainhoa, Xiangdong Liu, Andrea Lisco, et al.. (2024). Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients. Frontiers in Immunology. 15. 1352330–1352330.

Pérez‐Díez, Ainhoa, Xiangdong Liu, Andrea Lisco, et al.. (2023). Prevalence and complement activation of anti-lymphocyte IgM antibodies in hospitalized COVID-19 patients. The Journal of Immunology. 210(Supplement_1). 75.26–75.26. 1 indexed citations

Friedman-Klabanoff, DeAnna, Megan Birkhold, Timothy R. Wilson, et al.. (2022). Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial. EBioMedicine. 86. 104375–104375. 15 indexed citations

Hicks, Jennifer, Carleen Klumpp‐Thomas, Heather Kalish, et al.. (2021). Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses. Journal of Clinical Immunology. 41(5). 906–913. 107 indexed citations

Klumpp‐Thomas, Carleen, Heather Kalish, Jennifer Hicks, et al.. (2020). Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay Performance. The Journal of Infectious Diseases. 223(5). 802–804. 18 indexed citations

Manning, Jessica E., Fabiano Oliveira, Iliano V. Coutinho-Abreu, et al.. (2020). Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial. The Lancet. 395(10242). 1998–2007. 45 indexed citations

Pleguezuelos, Olga, Emma L. James, Ana M. Fernández, et al.. (2020). Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study. npj Vaccines. 5(1). 22–22. 61 indexed citations

Giurgea, Luca T., Alison Han, & Matthew J. Memoli. (2020). Universal coronavirus vaccines: the time to start is now. npj Vaccines. 5(1). 43–43. 29 indexed citations

10.

Han, Alison, Jiat Ling Poon, John H. Powers, et al.. (2018). Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model. BMC Infectious Diseases. 18(1). 353–353. 20 indexed citations

11.

Wang, Taia T., Jaturong Sewatanon, Matthew J. Memoli, et al.. (2017). IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity. Science. 355(6323). 395–398. 241 indexed citations breakdown →

12.

Chertow, Daniel S. & Matthew J. Memoli. (2013). Bacterial Coinfection in Influenza. JAMA. 309(3). 275–275. 291 indexed citations

13.

Memoli, Matthew J., Hillery A. Harvey, David M. Morens, & Jeffery K. Taubenberger. (2012). Influenza in pregnancy. Influenza and Other Respiratory Viruses. 7(6). 1033–1039. 32 indexed citations

14.

Kash, John C., Li Qi, Vivien G. Dugan, et al.. (2010). Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus. Influenza and Other Respiratory Viruses. 4(3). 121–127. 31 indexed citations

15.

Memoli, Matthew J., et al.. (2010). MultiDrug-Resistant 2009 Pandemic Influenza A(H1N1) Viruses Maintain Fitness and Transmissibility in Ferrets. The Journal of Infectious Diseases. 203(3). 348–357. 60 indexed citations

16.

Memoli, Matthew J., et al.. (2010). Rapid Selection of a Transmissible Multidrug‐Resistant Influenza A/H3N2 Virus in an Immunocompromised Host. The Journal of Infectious Diseases. 201(9). 1397–1403. 35 indexed citations

17.

Memoli, Matthew J., et al.. (2010). Rapid Selection of Oseltamivir‐ and Peramivir‐Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised Hosts. Clinical Infectious Diseases. 50(9). 1252–1255. 125 indexed citations

18.

Memoli, Matthew J., et al.. (2009). Recent Human Influenza A/H3N2 Virus Evolution Driven by Novel Selection Factors in Addition to Antigenic Drift. The Journal of Infectious Diseases. 200(8). 1232–1241. 37 indexed citations

19.

Memoli, Matthew J., Terrence M. Tumpey, Brett W. Jagger, et al.. (2009). An early ‘classical’ swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice. Virology. 393(2). 338–345. 47 indexed citations

20.

Vázquez, Susana, Patricio Yankilevich, Silvia H. Coria, et al.. (2008). Bizionia argentinensis sp. nov., isolated from surface marine water in Antarctica. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 58(10). 2363–2367. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact